ROSG Key Stats
SA Breaking News01/19 17:38
SA Breaking News12/23 10:20
SA Breaking News12/17 10:10
SA Breaking News11/24 12:15
|09/18/2014 10:00 EDT||Misc||Rosetta Genomics Ltd Q2 2014 Earnings Conference Call|
|09/18/2014||Earnings||Rosetta Genomics Ltd Q2 2014 Earnings Results|
|04/01/2014 10:00 EDT||Misc||Rosetta Genomics, Ltd. Q4 2013 Earning Conference Call|
|03/31/2014||Earnings||Rosetta Genomics, Ltd. Q4 2013 Earning Result|
ROSG Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Rosetta Genomics is down 18.87% over the last year vs S&P 500 Total Return up 14.71%, Marina Biotech down 10.14%, and Biocept up N/A.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for ROSG
Portfolio Strategies Featuring ROSG
Did Rosetta Genomics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Diagnostics & Research
- Company Website: http://www.rosettagenomics.com
- IR Website: http://www.rosettagenomics.com/investors
- HQ Country: Israel
- HQ State/Province: N/A
- Incorporation Country: Israel
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: March 31, 2015
- Est. Current Fiscal Year End: December 31, 2015
- Last Fiscal Quarter End: June 30, 2014
- Last Fiscal Year End: December 31, 2013
- Next Earnings Release: N/A
Rosetta Genomics Ltd is engaged in the development and commercialization of new diagnostic tests and therapeutics based on a group of genes known as microRNAs.
ROSG Excel Add-In Codes
- Name: =YCI("ROSG","name")
- Description: =YCI("ROSG","description")
- Sector: =YCI("ROSG","sector")
- Industry: =YCI("ROSG","industry")
- Est. Current Fiscal Year End: =YCI("ROSG","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.